日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial

Mosunetuzumab 与 polatuzumab vedotin 联合治疗复发或难治性侵袭性大 B 细胞淋巴瘤:一项 1b/2 期临床试验

Lihua E Budde, Adam J Olszewski, Sarit Assouline, Izidore S Lossos, Catherine Diefenbach, Manali Kamdar, Nilanjan Ghosh, Dipenkumar Modi, Waleed Sabry, Seema Naik, Amitkumar Mehta, Shazia K Nakhoda, Stephen D Smith, Kathleen Dorritie, Ting Jia, Song Pham, Ling-Yuh Huw, Jing Jing, Hao Wu, Wahib S Ead

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models

通过临床前模型鉴定的T细胞和NK细胞淋巴瘤中的可靶向脆弱性

Samuel Y Ng ,Noriaki Yoshida ,Amanda L Christie ,Mahmoud Ghandi ,Neekesh V Dharia ,Joshua Dempster ,Mark Murakami ,Kay Shigemori ,Sara N Morrow ,Alexandria Van Scoyk ,Nicolas A Cordero ,Kristen E Stevenson ,Maneka Puligandla ,Brian Haas ,Christopher Lo ,Robin Meyers ,Galen Gao ,Andrew Cherniack ,Abner Louissaint Jr ,Valentina Nardi ,Aaron R Thorner ,Henry Long ,Xintao Qiu ,Elizabeth A Morgan ,David M Dorfman ,Danilo Fiore ,Julie Jang ,Alan L Epstein ,Ahmet Dogan ,Yanming Zhang ,Steven M Horwitz ,Eric D Jacobsen ,Solimar Santiago ,Jian-Guo Ren ,Vincent Guerlavais ,D Allen Annis ,Manuel Aivado ,Mansoor N Saleh ,Amitkumar Mehta ,Aviad Tsherniak ,David Root ,Francisca Vazquez ,William C Hahn ,Giorgio Inghirami ,Jon C Aster ,David M Weinstock ,Raphael Koch

Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets

接受顺铂化疗的晚期阴茎鳞状细胞癌的基因表达谱可改善预后并确定潜在的治疗靶点

Andrea Necchi, Bernhard J Eigl, Eddy Shih-Hsin Yang, Sejong Bae, Darshan Chandrashekar, Dongquan Chen, Gurudatta Naik, Amitkumar Mehta, Patrizia Giannatempo, Maurizio Colecchia, Jennifer Gordetsky, Shi Wei, Tiffiny Cooper, Sooryanarayana Varambally, Guru Sonpavde